CRSP vs SOFI · rev $11.6M vs P/E 39, rev $283.1M
Crispr Therapeutics AG (CRSP) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
CRSP currently screens at market cap $5.42B. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the CRSP and SOFI stock pages for the full models.
Not investment advice.